Wednesday, March 05, 2025 | 04:33 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Biological E recipient of mRNA tech as part of WHO's tech transfer hub

WHO and partners to work with Indian govt and the firm to develop roadmap and put in place training and support for Biological E to start producing mRNA vaccines at the earliest

biological e
Premium

Biological E's pharma plant in Shamirpet

Sohini Das Mumbai
Hyderabad-based Biological E will partner with the World Health Organisation to make mRNA technology based vaccines here as a part of the Technology Transfer Hub project.

The firm has been selected by the WHO Advisory committee on Vaccine Product Development (ACPDV) after examining several proposals from India as a recipient of the mRNA technology from the WHO technology transfer hub.

Biological E said on Monday that WHO and their partners would work with the Indian government and the company to develop a roadmap and put in place the necessary training and support for Biological E to start producing mRNA vaccines

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in